Skip to NavigationSkip to content

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

Published on 04/03/20 at 09:33am
Official White House Photo by Shealah Craighead

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus vaccine.

Executives from Gilead Sciences, GlaxoSmithKline, Inovio pharmaceuticals, Moderna and Regeneron Pharmaceuticals were all in attendance.

Commenting on the gathering, Trump said: “They're really working hard and they're working smart. We had a great meeting with a lot of great companies. They're going to have vaccines, I think, relatively soon, and they're going to have something that makes you better, and that's actually going to take place even sooner. I don't know what the time will be. I've heard very quick numbers, that of months. And I've heard pretty much a year would be an outside number.”

However, Trump’s timeline does not seem realistic and Antony Fauci, the head of the National Institute of Allergy and Infectious Diseases, said that a deployable vaccine is “going to be, at the earliest, a year to a year and a half.” This is backed up by the pharmaceutical companies with John Shiver, Senior Vice President of global vaccine R&D at Sanofi, who also attended the meeting, saying that a therapeutic for the virus could be developed “months or a very short amount of time, a year or so.”

Gilead’s drug remdesivir, originally developed for Ebola, has been tested since January on coronavirus patients and is currently in clinical trials.

Conor Kavanagh


Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches